General Information
Repros Low Testosterone ZA-301
A Randomized, Double Blind, Placebo and Active (Testim®) Controlled, Dose Titration, Parallel, Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Younger (<60) Overweight (BMI=25) Men with Secondary Hypogonadism with Confirmed Morning Testosterone Levels <300 ng/dL That Wish to Preserve Their Reproductive Status and are not Currently Being Treated with Topical Testosterone
| Protocol | |
|---|---|
| Identifier | ZA-301 |
| UID | b4bb6798-ef15-4177-9233-630a741eca16 |
| Status | PI Declined |
| Phase | 3 |
| Category | Low Testosterone |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2012-05-08 12:29 |
| Last Updated | 2012-05-08 12:29 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Unger, Jeffrey | JUnger | No |
| Recruiter | - | No | |
| Coordinator | Mata, Nelly | NMata | No |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Repros Therapeutics Inc. |
|---|---|
| Division | Repros Therapeutics Inc. |
| Team | Repros Therapeutics Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gray |
| Currency | - |
